Annual Accounts Payable
$3.51 M
-$1.76 M-33.37%
31 December 2023
Summary:
Relmada Therapeutics annual accounts payable is currently $3.51 million, with the most recent change of -$1.76 million (-33.37%) on 31 December 2023. During the last 3 years, it has fallen by -$4.84 million (-57.99%). RLMD annual accounts payable is now -68.68% below its all-time high of $11.19 million, reached on 31 December 2021.RLMD Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.35 M
-$1.83 M-43.81%
30 September 2024
Summary:
Relmada Therapeutics quarterly accounts payable is currently $2.35 million, with the most recent change of -$1.83 million (-43.81%) on 30 September 2024. Over the past year, it has dropped by -$511.30 thousand (-17.90%). RLMD quarterly accounts payable is now -81.54% below its all-time high of $12.71 million, reached on 30 September 2021.RLMD Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLMD Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.4% | -17.9% |
| 3 y3 years | -58.0% | -81.5% |
| 5 y5 years | +279.3% | +85.2% |
RLMD Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -68.7% | at low | -81.5% | at low |
| 5 y | 5 years | -68.7% | +570.8% | -81.5% | +221.9% |
| alltime | all time | -68.7% | >+9999.0% | -81.5% | >+9999.0% |
Relmada Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.35 M(-43.8%) |
| June 2024 | - | $4.17 M(-19.6%) |
| Mar 2024 | - | $5.19 M(+48.0%) |
| Dec 2023 | $3.51 M(-33.4%) | $3.51 M(+22.7%) |
| Sept 2023 | - | $2.86 M(-41.1%) |
| June 2023 | - | $4.85 M(+9.8%) |
| Mar 2023 | - | $4.42 M(-16.0%) |
| Dec 2022 | $5.26 M(-53.0%) | $5.26 M(-49.5%) |
| Sept 2022 | - | $10.43 M(+38.3%) |
| June 2022 | - | $7.54 M(-29.3%) |
| Mar 2022 | - | $10.67 M(-4.7%) |
| Dec 2021 | $11.19 M(+34.1%) | $11.19 M(-11.9%) |
| Sept 2021 | - | $12.71 M(+21.5%) |
| June 2021 | - | $10.46 M(+29.4%) |
| Mar 2021 | - | $8.08 M(-3.2%) |
| Dec 2020 | $8.35 M(+1496.8%) | $8.35 M(+1045.6%) |
| Sept 2020 | - | $728.60 K(-24.5%) |
| June 2020 | - | $965.20 K(-12.5%) |
| Mar 2020 | - | $1.10 M(-12.9%) |
| Dec 2019 | $522.70 K(-43.5%) | - |
| Sept 2019 | - | $1.27 M(+37.0%) |
| June 2019 | $924.40 K | $924.40 K(-14.4%) |
| Mar 2019 | - | $1.08 M(+200.9%) |
| Dec 2018 | - | $358.90 K(-64.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $1.02 M(+33.2%) |
| June 2018 | $765.40 K(+44.5%) | $765.40 K(-29.9%) |
| Mar 2018 | - | $1.09 M(+281.5%) |
| Dec 2017 | - | $286.10 K(-18.4%) |
| Sept 2017 | - | $350.50 K(-33.8%) |
| June 2017 | $529.60 K(-58.0%) | $529.60 K(+57.9%) |
| Mar 2017 | - | $335.40 K(+9.2%) |
| Dec 2016 | - | $307.20 K(-54.3%) |
| Sept 2016 | - | $671.70 K(-46.7%) |
| June 2016 | $1.26 M(+50.8%) | $1.26 M(+69.3%) |
| Mar 2016 | - | $744.20 K(-55.9%) |
| Dec 2015 | - | $1.69 M(+46.8%) |
| Sept 2015 | - | $1.15 M(+37.7%) |
| June 2015 | $835.30 K(+12.0%) | $835.30 K(+114.0%) |
| Mar 2015 | - | $390.40 K(-59.8%) |
| Dec 2014 | - | $970.00 K(+55.3%) |
| Sept 2014 | - | $624.70 K(+1416.3%) |
| June 2014 | $746.10 K(+2113.9%) | - |
| Feb 2014 | - | $41.20 K(+2.2%) |
| Nov 2013 | - | $40.30 K(+19.6%) |
| Aug 2013 | $33.70 K(+381.4%) | $33.70 K(+30.6%) |
| May 2013 | - | $25.80 K(+115.0%) |
| Feb 2013 | - | $12.00 K(+71.4%) |
| Aug 2012 | $7000.00 | $7000.00 |
FAQ
- What is Relmada Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Relmada Therapeutics?
- What is Relmada Therapeutics annual accounts payable year-on-year change?
- What is Relmada Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly accounts payable year-on-year change?
What is Relmada Therapeutics annual accounts payable?
The current annual accounts payable of RLMD is $3.51 M
What is the all time high annual accounts payable for Relmada Therapeutics?
Relmada Therapeutics all-time high annual accounts payable is $11.19 M
What is Relmada Therapeutics annual accounts payable year-on-year change?
Over the past year, RLMD annual accounts payable has changed by -$1.76 M (-33.37%)
What is Relmada Therapeutics quarterly accounts payable?
The current quarterly accounts payable of RLMD is $2.35 M
What is the all time high quarterly accounts payable for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly accounts payable is $12.71 M
What is Relmada Therapeutics quarterly accounts payable year-on-year change?
Over the past year, RLMD quarterly accounts payable has changed by -$511.30 K (-17.90%)